Opioid Use Disorder (Secondary to Prescribed Pain Management) Secondary to Chronic Pain Condition / Opioid Therapy (Service-Connected)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Opioid Use Disorder (Secondary to Prescribed Pain Management) is a documented secondary pairing for Chronic Pain Condition / Opioid Therapy (Service-Connected) with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Opioid Use Disorder (Secondary to Prescribed Pain Management) separately under its own 38 CFR Part 4 diagnostic code, then combines it with Chronic Pain Condition / Opioid Therapy (Service-Connected) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Opioid Use Disorder (Secondary to Prescribed Pain Management) as secondary to Chronic Pain Condition / Opioid Therapy (Service-Connected) is rated strong. Opioid use disorder (OUD) developing in the context of legitimate opioid prescribing for a service-connected chronic pain condition is compensable under 38 CFR § 3.310. Prescribed opioids (oxycodone, hydrocodone, morphine, tramadol) cause neuroadaptive changes in the mesolimbic dopamine system — specifically, opioid receptor downregulation and cAMP supersensitivity — that produce physical dependence and withdrawal syndromes. Chronic opioid exposure also causes paradoxical opioid-induced hyperalgesia (OIH), increasing pain sensitivity and driving dose escalation. The transition from therapeutic use to OUD involves μ-opioid receptor-mediated reward sensitization in the nucleus accumbens and prefrontal cortex executive control deficits that reduce the ability to moderate use despite consequences. Veterans with chronic pain prescribed opioids for service-connected conditions are at elevated OUD risk due to comorbid PTSD, depression, and the neurobiological overlap between pain and addictive disorders.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.